- Home
- TRMD vs IDYA Comparison
TRMD vs IDYA Comparison
Compare TRMD & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMD
- IDYA
- Stock Information
- Founded
- TRMD 1889
- IDYA 2015
- Country
- TRMD United Kingdom
- IDYA United States
- Employees
- TRMD N/A
- IDYA N/A
- Industry
- TRMD Marine Transportation
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- TRMD Consumer Discretionary
- IDYA Health Care
- Exchange
- TRMD Nasdaq
- IDYA Nasdaq
- Market Cap
- TRMD 2.1B
- IDYA 2.3B
- IPO Year
- TRMD N/A
- IDYA 2019
- Fundamental
- Price
- TRMD $20.36
- IDYA $26.96
- Analyst Decision
- TRMD Buy
- IDYA Buy
- Analyst Count
- TRMD 1
- IDYA 15
- Target Price
- TRMD $23.00
- IDYA $47.92
- AVG Volume (30 Days)
- TRMD 649.5K
- IDYA 1.2M
- Earning Date
- TRMD 11-06-2025
- IDYA 11-03-2025
- Dividend Yield
- TRMD 12.76%
- IDYA N/A
- EPS Growth
- TRMD N/A
- IDYA N/A
- EPS
- TRMD 3.31
- IDYA N/A
- Revenue
- TRMD $1,321,800,000.00
- IDYA $7,000,000.00
- Revenue This Year
- TRMD N/A
- IDYA $63.41
- Revenue Next Year
- TRMD N/A
- IDYA $305.49
- P/E Ratio
- TRMD $6.16
- IDYA N/A
- Revenue Growth
- TRMD N/A
- IDYA N/A
- 52 Week Low
- TRMD $13.60
- IDYA $13.45
- 52 Week High
- TRMD $33.15
- IDYA $32.67
- Technical
- Relative Strength Index (RSI)
- TRMD 40.33
- IDYA 58.57
- Support Level
- TRMD $20.41
- IDYA $26.88
- Resistance Level
- TRMD $21.98
- IDYA $28.41
- Average True Range (ATR)
- TRMD 0.46
- IDYA 1.01
- MACD
- TRMD -0.22
- IDYA 0.08
- Stochastic Oscillator
- TRMD 2.90
- IDYA 58.38
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.